–56 This relationship suggests that WST-D/NIR treatment might have a targeted effect on the pathways involved in keratoconus, by reversing the dysregulation of MMP-2 in keratoconus by the upregulation of TIMP-2. The gene discussed is MMP2; the disease is keratoconus.